InChI=1S/C46H84NO8P/c1-6-8-10-12-14-16-18-20-22-23-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-24-21-19-17-15-13-11-9-7-2/h14,16,20,22,25,27,31,33,44H,6-13,15,17-19,21,23-24,26,28-30,32,34-43H2,1-5H3/b16-14-,22-20-,27-25-,33-31-/t44-/m1/s1 |
PSVRFUPOQYJOOZ-QNPWAGBNSA-N |
O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)O[C@@H](COP(OCC[N+](C)(C)C)(=O)[O-])COC(=O)CCCCCCCCCCCCCCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 38:4 )
|
|
(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
|
(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-(stearoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
|
IUPAC
|
1-C18:0-2-C20:4(ω-6)-phosphatidylcholine
|
SUBMITTER
|
1-octadecanoyl-2-(5Z,8Z,11Z,14Z)-icosatetraenoyl-sn-glycero-3-phosphocholine
|
SUBMITTER
|
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
|
UniProt
|
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
|
LIPID MAPS
|
1-stearoyl-2-arachidonoyl-GPC
|
ChEBI
|
1-stearoyl-2-arachidonoyl-GPC (18:0/20:4)
|
ChEBI
|
1-stearoyl-2-arachidonoylphosphatidylcholine
|
LIPID MAPS
|
GPC(18:0/20:4)
|
ChEBI
|
PC(18:0/20:4(5Z,8Z,11Z,14Z))
|
LIPID MAPS
|
PC(18:0/20:4)
|
LIPID MAPS
|
PC(18:0/20:4n6)
|
HMDB
|
PC(18:0/20:4ω6)
|
HMDB
|
PC(18:0/20:4w6)
|
HMDB
|
PC(38:4)
|
HMDB
|
Phosphatidylcholine(18:0/20:4)
|
HMDB
|
Phosphatidylcholine(18:0/20:4n6)
|
HMDB
|
Phosphatidylcholine(18:0/20:4ω6)
|
LIPID MAPS
|
Phosphatidylcholine(18:0/20:4w6)
|
HMDB
|
Phosphatidylcholine(38:4)
|
HMDB
|